The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy-Reference-Cited by-同舟云学术

The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy

Published:2011-07-08 Issue:10 Volume:60 Page:1373-1381
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Berghella Anna Maria,Pellegrini Patrizia,Del Beato Tiziana,Ciccone Fabiana,Contasta Ida

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://www.springerlink.com/index/pdf/10.1007/s00262-011-1068-5

Reference61 articles.

1. Disis ML (2011) Immunologic biomarkers as correlates of clinical response to cancer immunotherapy. Cancer Immunol Immunother 60:433–442

2. Beachy SH, Repasky EA (2008) Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update. Cancer Immunol Immunother 57:759–775

3. Uno K, Okuno K, Kato T et al (2010) Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patients. Cancer Immunol Immunother 59:1457–1465

4. Soini Y, Kahlos K, Näpänkangas U et al (2001) Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin Cancer Res 7:1750–1757

5. Kakolyris S, Giatromanolaki A, Koukourakis M et al (2001) Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Clin Cancer Res 7:3087–3091

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Prevention Strategies to Defeat Cancer;Cancer Immunology;2020-09-25

2. Thioredoxin‐1 as a biological predictive marker for selecting diffuse large B‐cell lymphoma patients for etoposide‐containing treatment;European Journal of Haematology;2020-04-16

3. Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer;Scientific Reports;2019-12

4. Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer;World Journal of Gastrointestinal Oncology;2019-02-15

5. Translational Bioinformatics and Systems Biology for Cancer Precision Medicine;Translational Bioinformatics and Systems Biology Methods for Personalized Medicine;2017